Trademark: 88585565
Word
BIONDIS
Status
Registered
Status Code
700
Status Date
Tuesday, April 14, 2020
Serial Number
88585565
Registration Number
6032608
Registration Date
Tuesday, April 14, 2020
Mark Type
4000
Filing Date
Tuesday, August 20, 2019
Published for Opposition
Tuesday, January 28, 2020

Trademark Owner History

Classifications
5 Biopharmaceutical preparations, substances and compositions, namely, antibacterial substances for medical purposes, medical diagnostic reagents in the nature of antibody-drug conjugates, immuno-oncology compounds in the nature of medicinal preparations for the treatment of infectious diseases and for use in oncology, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; biopharmaceutical active substances, namely, diagnostic agents, preparations and substances for medical purposes in the nature of antibody-drug conjugates, immuno-oncology compounds, namely, pharmaceutical preparations and substances for the treatment of oncological related diseases and disorders, and compounds for auto-immune diseases, namely, pharmaceutical preparations for the treatment of immune system related diseases and disorders; biological and biochemical drug and cultures for medical use, namely, biological preparations for the treatment of cancer, cultures of microorganisms for medical use, and biological tissue cultures for medical purposes; biopharmaceutical active substances, namely, nutritive substances for microorganism cultures; biopharmaceutical components and ingredients, namely, plant and herb extracts sold as components of medicated cosmetics; orthopedic articles, namely, bone repair paste for use in orthopedic surgery; all of the above excluding for the treatment of neuromuscular diseases and disorders
35 Providing office functions relating to the registration of pharmaceutical preparations and components and pharmaceutical drugs; providing office functions relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files; business mediation of commercial transactions for others, mediation of contracts for the purchase and sale of products, and mediation of agreements all in the field of the purchase, sale and licensing of pharmaceutical registrations and pharmaceutical registration files
10 Surgical and medical devices, apparatus and instruments, namely, surgical instruments and apparatus, surgical devices and instruments, surgical apparatus and instruments, medical instruments for cutting tissue, and medical instrument for performing biopsies, medical fluid injectors, injection device for pharmaceuticals, syringes for medical purposes, disposable syringes for medical purposes; orthopedic articles, namely, orthopedic walkers, orthopedic supports, orthopedic braces and orthopedic cushions; injection apparatus for medical purposes, namely, injection needles and injection instruments with needles
42 Scientific and technological services and research relating thereto, namely, scientific research, analysis and testing in the fields of antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases and scientific research related thereto; scientific and technological services relating to obtaining pharmaceutical registrations and compiling pharmaceutical registration files, namely, scientific research in the field of pharmaceuticals for pharmaceutical registration purposes; pharmaceutical research services and pharmaceutical research consultancy services; biomedical research services and biomedical research consultancy; medical research and medical research consultancy; scientific laboratory services in the fields of chemistry and biology, antibody-drug conjugates, immuno-oncology compounds and compounds for auto-immune diseases; scientific laboratory services; product development of pharmaceutical products and ingredients for pharmaceuticals; providing information relating to medical and scientific research in the field of pharmaceutical preparations; providing medical and scientific research information regarding the results of clinical trials for pharmaceutical preparations; quality control of products for others to determine conformity with certification standards; laboratory research, namely, scientific and medical research; laboratory analysis in the field of chemistry and biology as related to pharmaceuticals; product research for the pharmaceutical industry; design of pharmaceuticals for the pharmaceutical industry; product research and development for others; drug discovery services; testing in the context of quality control, namely, material testing and product testing; conducting clinical trials for others in the field of pharmaceutical preparations; quality control for others in the field of pharmaceutical preparations; providing information and data relating product research and developments in the pharmaceutical, biopharmaceutical and medical fields

Trademark Events
Nov 21, 2022
Teas Change Of Correspondence Received
Nov 21, 2022
Teas Change Of Domestic Representatives Address
Nov 21, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Nov 21, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
May 13, 2020
Automatic Update Of Assignment Of Ownership
Apr 14, 2020
Registered-Principal Register
Jan 28, 2020
Official Gazette Publication Confirmation E-Mailed
Jan 28, 2020
Published For Opposition
Jan 8, 2020
Notification Of Notice Of Publication E-Mailed
Dec 19, 2019
Approved For Pub - Principal Register
Dec 12, 2019
Assigned To Examiner
Dec 11, 2019
Examiner's Amendment Entered
Dec 11, 2019
Notification Of Examiners Amendment E-Mailed
Dec 11, 2019
Examiners Amendment E-Mailed
Dec 11, 2019
Examiners Amendment -Written
Dec 11, 2019
Assigned To Examiner
Dec 9, 2019
Notification Of Non-Final Action E-Mailed
Dec 9, 2019
Non-Final Action E-Mailed
Dec 9, 2019
Non-Final Action Written
Dec 2, 2019
Teas/Email Correspondence Entered
Dec 2, 2019
Correspondence Received In Law Office
Nov 29, 2019
Teas Response To Office Action Received
Nov 20, 2019
Notification Of Non-Final Action E-Mailed
Nov 20, 2019
Non-Final Action E-Mailed
Nov 20, 2019
Non-Final Action Written
Nov 19, 2019
Assigned To Examiner
Nov 5, 2019
Preliminary/Voluntary Amendment - Entered
Oct 31, 2019
Assigned To Lie
Oct 25, 2019
Teas Voluntary Amendment Received
Sep 5, 2019
New Application Office Supplied Data Entered In Tram
Aug 23, 2019
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24